Epidrugs in precision medicine, the plausible way forward / Profesor Dr Ahmed Mahmoud Ahmed Alafify

It is not only our genes that control how our bodies respond to drugs and cope with disease states, but also by identifying the modifications to our histone proteins that regulate gene expression, we can discover a whole new direction for diagnostic and therapeutic biomarkers and drug targets as wel...

Full description

Saved in:
Bibliographic Details
Main Author: Ahmed Alafify, Ahmed Mahmoud (Author)
Format: Book
Published: Faculty of Pharmacy, 2023-02.
Subjects:
Online Access:Link Metadata
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 repouitm_74302
042 |a dc 
100 1 0 |a Ahmed Alafify, Ahmed Mahmoud  |e author 
245 0 0 |a Epidrugs in precision medicine, the plausible way forward / Profesor Dr Ahmed Mahmoud Ahmed Alafify 
260 |b Faculty of Pharmacy,   |c 2023-02. 
500 |a https://ir.uitm.edu.my/id/eprint/74302/2/74302.pdf 
520 |a It is not only our genes that control how our bodies respond to drugs and cope with disease states, but also by identifying the modifications to our histone proteins that regulate gene expression, we can discover a whole new direction for diagnostic and therapeutic biomarkers and drug targets as well.In the last two decades, epidrugs have been developed to target the histone-modifying enzymes. It could be defined as small-molecular entities that inhibit epigenome and/or enzymes with epigenetic activity. Many preclinical evidence suggested that targeting epigenetic deregulation is an effective strategy to combat human diseases. However, implementing epidrugs in clinical practice is mainly limited to haematological malignancies. 
546 |a en 
690 |a RS Pharmacy and materia medica 
655 7 |a Article  |2 local 
655 7 |a PeerReviewed  |2 local 
787 0 |n https://ir.uitm.edu.my/id/eprint/74302/ 
787 0 |n https://pharmacy.uitm.edu.my/ 
856 4 1 |u https://ir.uitm.edu.my/id/eprint/74302/  |z Link Metadata